See how science, strategy, and innovation are transforming the GLP-1 space: #GLP1 #oralGLP1 #metabolichealth #diabetescare #obesity #obesitytreatment #pharmainnovation #futureproofingbusinesses #IeB To view or add a comment, sign in #MIMSPharmaMarketInsightUpdate, September 2025 Including: SGLT2 inhibitors should be offered first-line to people with heart failure with reduced ejection fraction A new formulation of Rybelsus (semaglutide) tablets has been released The first inhaled levodopa product, Inbrija (levodopa), has been launched
There were no associations with duration of treatment, or symptom changes
Evidence-Inspired Formulas
That patient probably needs to be monitored much more closely and to think much more deeply about whether or not a GLP-1 is right for them, he said
Can you explain in detail what GLP-1 is and how it relates to weight loss
For those exploring mobile, the convenience factor often begins with streamlined onboarding and direct access to favorite categories